AI-Generated Summary

A new cross-party parliamentary group is advocating for the expansion of a proposed Biotech Act beyond its current health-centric scope. This initiative, reported by Euractiv, is seen by industry sources as a move to exert pressure on key European officials regarding the legislation.

In a nutshell

This development signals potential shifts in the regulatory landscape for biotech, with implications for how biotechnological advancements are governed and applied across various sectors, not just healthcare.

Source: Euractiv